Cost-effective, comprehensive, personalized pharmacogenomic analysis — integrated into patients' everyday clinical care
Up to 95% of your response to drugs is genetically determined, and how you metabolize drugs is one of the factors contributing to that response.1 With pharmacogenomics (PGx), we identify which inherited genetic variations a person has to predict how an individual will — or will not — metabolize a drug.
How people metabolize drugs
In addition to standard characteristics such as sex, age, race, and liver function, PGx results may help your physician prescribe you the right medication. Knowing your metabolizer status for many drugs will help your physician determine which drug may work for you and reduces the trial-and-error approach. Being a "normal" metabolizer means your physician can prescribe a drug as directed by the FDA label. If you are a poor metabolizer, you may need a dosage adjustment to avoid side effects or improve the drug’s effectiveness. Your metabolizer status is determined by your genes, which never change; thus, if you are a poor metabolizer of a given drug, you will always be a poor metabolizer of that drug.
PGx has the potential to increase the safety and effectiveness of drug treatments by incorporating genetic data to better predict an individual’s response to medications and adverse drug reactions (ADRs).
Adverse drug reactions (ADRs) are the fourth leading cause of death in the U.S., and according to the FDA, cost $136 billion annually. 2
Co-developed and exclusively licensed from Mayo Clinic, OneOme’s unique platform is:
Benefits of the OneOme RightMed PGx test
Our goal is to bring reliable, comprehensive pharmacogenomic insights to providers and patients.
When testing can help
Until now, providers and pharmacists had to rely on trial and error to find the right drug for each patient. OneOme brings clarity and insight into new and existing medication. OneOme's RightMed PGx test may help with:
Because DNA does not change with time, the OneOme RightMed PGx test may provide years of more accurate decision-making.